Form 4 for DXCM Dexcom
Accepted 2026-09-10 16:40:16 ET · period of report 2026-09-10 · accession 0001093557-26-000171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:40 | 2026-09-10 | DXCM | Boehnlein Glenn S | Dir | A - Grant | $0.00 | +5,841 | 5,841 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | A | A | 5,841 | $0.00 | 5,841 | D | — | — | (F1) Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. |